Rapid Micro Biosystems Inc [RPID] stock is trading at $1.26, up 16.06%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The RPID shares have gain 21.63% over the last week, with a monthly amount glided 24.02%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Rapid Micro Biosystems Inc [NASDAQ: RPID] stock has seen the most recent analyst activity on August 16, 2022, when JP Morgan downgraded its rating to a Neutral.
Rapid Micro Biosystems Inc [RPID] stock has fluctuated between $0.58 and $1.45 over the past year. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Rapid Micro Biosystems Inc [NASDAQ: RPID] shares were valued at $1.26 at the most recent close of the market. An investor can expect a potential return of 534.92% based on the average RPID price forecast.
Analyzing the RPID fundamentals
Rapid Micro Biosystems Inc [NASDAQ:RPID] reported sales of 26.17M for the trailing twelve months, which represents a growth of 23.74%. Gross Profit Margin for this corporation currently stands at -0.05% with Operating Profit Margin at -1.98%, Pretax Profit Margin comes in at -1.85%, and Net Profit Margin reading is -1.85%. To continue investigating profitability, this company’s Return on Assets is posted at -0.46, Equity is -0.48 and Total Capital is -0.58. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1700 points at the first support level, and at 1.0750 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.3500, and for the 2nd resistance point, it is at 1.4350.
Ratios To Look Out For
For context, Rapid Micro Biosystems Inc’s Current Ratio is 5.52. Further, the Quick Ratio stands at 4.19, while the Cash Ratio is 1.38. Considering the valuation of this stock, the price to sales ratio is 2.08, the price to book ratio is 0.65.
Transactions by insiders
Recent insider trading involved PEI MELINDA LITHERLAND, Director, that happened on Dec 03 ’24 when 10880.0 shares were purchased. Director, PEI MELINDA LITHERLAND completed a deal on Dec 05 ’24 to buy 9120.0 shares. Meanwhile, Director PEI MELINDA LITHERLAND bought 19892.0 shares on Nov 27 ’24.
